RAS/MAPK PATHWAY VASCULAR ANOMALIES

Clinical trials for RAS/MAPK PATHWAY VASCULAR ANOMALIES explained in plain language.

Never miss a new study

Get alerted when new RAS/MAPK PATHWAY VASCULAR ANOMALIES trials appear

Sign up with your email to follow new studies for RAS/MAPK PATHWAY VASCULAR ANOMALIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Cancer drug shows promise for rare blood vessel disorders in kids

Disease control Ongoing

This study tests the drug trametinib, already approved for melanoma, in people aged 2 months to 30 years with rare blood vessel growth problems caused by a specific gene pathway. The goal is to see if the drug can shrink abnormal vessels and improve quality of life. Participants …

Matched conditions: RAS/MAPK PATHWAY VASCULAR ANOMALIES

Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control

Last updated May 11, 2026 20:39 UTC

RAS/MAPK PATHWAY VASCULAR ANOMALIES

Get alerted when new RAS/MAPK PATHWAY VASCULAR ANOMALIES trials appear

Cancer drug shows promise for rare blood vessel disorders in kids